
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
Upturn AI SWOT
- About


Fonar Corporation (FONR)


- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)

(see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
10/15/2025: FONR (1-star) is currently NOT-A-BUY. Pass it for now.
Analysis of Past Performance
Type Stock | Historic Profit -1.54% | Avg. Invested days 42 | Today’s Advisory PASS |
Upturn Star Rating ![]() | Upturn Advisory Performance ![]() | Stock Returns Performance ![]() |
![]() | ![]() |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 93.69M USD | Price to earnings Ratio 11.9 | 1Y Target Price - |
Price to earnings Ratio 11.9 | 1Y Target Price - | ||
Volume (30-day avg) - | Beta 1 | 52 Weeks Range 12.00 - 18.68 | Updated Date 06/29/2025 |
52 Weeks Range 12.00 - 18.68 | Updated Date 06/29/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) 1.25 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 8.19% | Operating Margin (TTM) 13.48% |
Management Effectiveness
Return on Assets (TTM) 3.54% | Return on Equity (TTM) 6.91% |
Valuation
Trailing PE 11.9 | Forward PE - | Enterprise Value 78089814 | Price to Sales(TTM) 0.91 |
Enterprise Value 78089814 | Price to Sales(TTM) 0.91 | ||
Enterprise Value to Revenue 0.76 | Enterprise Value to EBITDA 3.37 | Shares Outstanding 6168460 | Shares Floating 6030734 |
Shares Outstanding 6168460 | Shares Floating 6030734 | ||
Percent Insiders 2.45 | Percent Institutions 49.08 |
Upturn AI SWOT
Fonar Corporation

Company Overview
History and Background
Fonar Corporation was founded in 1978 by Dr. Raymond Damadian, the inventor of the first MRI scanner. The company's initial focus was on developing and manufacturing whole-body MRI scanners. Over time, Fonar has expanded its product line and services, becoming a player in the diagnostic imaging industry.
Core Business Areas
- MRI Scanner Manufacturing: Designs, manufactures, and sells MRI scanners, including upright MRI scanners, which allow patients to be scanned in multiple positions.
- Diagnostic Imaging Services: Operates diagnostic imaging centers that provide MRI scanning services.
- Management and Administrative Services: Providing Management services to Medical Facilities.
Leadership and Structure
Dr. Raymond Damadian founded the corporation. The organizational structure is typical for a publicly traded company, with a board of directors and a management team responsible for day-to-day operations.
Top Products and Market Share
Key Offerings
- Upright MRI Scanner: Fonar is known for its Upright MRI scanner, which allows patients to be scanned in multiple positions, including standing, sitting, bending, and lying down. Market share data for upright MRI scanners specifically is limited, but Fonar is a key player in this niche market. Competitors include Siemens Healthineers, GE Healthcare, Philips Healthcare who have MRI scanners but not in the upright form.
- Diagnostic Imaging Services: Fonar operates diagnostic imaging centers that provide MRI scanning services. Revenue data is not readily available. Competitors include other diagnostic imaging centers, such as those owned by RadNet (RDNT).
Market Dynamics
Industry Overview
The diagnostic imaging industry is driven by technological advancements, aging populations, and increasing demand for accurate and non-invasive diagnostic procedures. The industry is competitive, with major players investing heavily in research and development.
Positioning
Fonar occupies a niche position in the MRI market with its upright MRI technology. This allows for a competitive advantage in specific clinical applications where positional imaging is valuable.
Total Addressable Market (TAM)
The global MRI market is expected to reach hundreds of millions USD, but the amount is expected to increase. Fonar is positioned to capture a portion of this market. Exact amount of market share Fonar has is difficult to discern, but they are a relatively small player.
Upturn SWOT Analysis
Strengths
- Unique Upright MRI Technology
- Established Brand Recognition
- Proprietary Technology
Weaknesses
- Smaller Market Share Compared to Major Competitors
- Limited Product Portfolio
- Financial Instability (Losses in Current Years)
Opportunities
- Expanding Diagnostic Imaging Services
- Developing New MRI Applications
- Partnerships with Healthcare Providers
Threats
- Competition from Larger MRI Manufacturers
- Technological Advancements by Competitors
- Changes in Healthcare Regulations
Competitors and Market Share
Key Competitors
- Siemens (SIE.DE)
- GE Healthcare (GE)
- Philips (PHG)
Competitive Landscape
Fonar's unique upright MRI technology provides a competitive advantage in specific clinical applications. However, the company faces significant competition from larger players with more comprehensive product portfolios and greater resources.
Growth Trajectory and Initiatives
Historical Growth: Fonar's growth has been limited compared to larger players in the MRI market.
Future Projections: Future growth depends on the company's ability to innovate, expand its services, and compete effectively.
Recent Initiatives: Recent initiatives are likely focused on improving operational efficiency and expanding into new markets.
Summary
Fonar Corporation is a niche player in the MRI market, primarily known for its upright MRI technology. While the company possesses a unique competitive advantage with its upright MRI, it faces challenges due to its smaller size and limited resources compared to its competitors. Its success hinges on continued innovation, strategic partnerships, and effective marketing of its unique value proposition. The company would need to work on its financial stability with Losses in current years.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company Financial Statements
- Industry Reports
- Market Research Reports
Disclaimers:
This analysis is based on publicly available information and is for informational purposes only. It is not financial advice. Market share data is estimated due to limited public information and may not be exact.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Fonar Corporation
Exchange NASDAQ | Headquaters Melville, NY, United States | ||
IPO Launch date 1987-01-01 | Chairman, President, CEO & Treasurer Mr. Timothy R. Damadian M.D. | ||
Sector Healthcare | Industry Diagnostics & Research | Full time employees 520 | Website https://www.fonar.com |
Full time employees 520 | Website https://www.fonar.com |
FONAR Corporation, together with its subsidiaries, engages in the designing, manufacturing, and selling magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases, abnormalities, other medical conditions, and injuries in the United States. It operates in two segments, Medical Equipment, and Physician Management and Diagnostic Services. The company offers Upright MRI scanner, allows patients to be scanned in weight-bearing conditions, such as standing, sitting, bending, or lying down. It also provides non-medical management, including administrative services, billing and collection services, credentialing services, contract negotiations, compliance consulting, purchasing IT services, hiring, conducting interviews, training, supervision and management of non-medical personnel, storage of medical records, office space, equipment, repair maintenance services, accounting, assistance with compliance matters, and development and implementation of practice growth and marketing strategies. In addition, the company owns and operates diagnostic imaging facilities. The company markets its scanners to private diagnostic imaging centers and hospital outpatient imaging facilities. FONAR Corporation was founded in 1978 and is based in Melville, New York.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.